In the past 52-week period, shares of Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) have moved within the range of $54.98 to $135.59. On the stock’s most recent trading day, the company’s shares ended the regular session at $56.35, which is 58.44% lower than its 52-week high.
Intercept Pharmaceuticals, Inc. (ICPT) has demonstrated a 20-day simple moving average (SMA) of -8.51%, and a 50-day SMA of -9.01%. This public company’s current market capitalization stands at $1.52 billion.Analyzing Consensus Estimates, Sales Revenue and Net Income
When considering entering a position, it is crucial to understand the average enthusiasm level expressed by Wall Street analysts for that particular stock. According to the latest data, the consensus recommendation for Intercept Pharmaceuticals, Inc. (ICPT) is Outperform.
Publicly-traded organizations typically post revenue and earnings results that fall either above or below the average Wall Street estimate. In the most recent quarterly financial report, for the quarter ending Sep. 2017, Intercept Pharmaceuticals, Inc. (ICPT) delivered a 11.68% surprise with its net revenue. Sales reached $0.04 billion during the three-month period, compared to the average analyst estimate of $0.04 billion.
Meanwhile, during the same quarter Intercept Pharmaceuticals, Inc. (ICPT) delivered a -14.61% earnings surprise. Net earnings for the quarter were posted at -$2.89 per share, whereas Wall Street had forecast -$3.38 per share.Ownership at Intercept Pharmaceuticals, Inc. (ICPT), According to Most Recent SEC Filings
We can find critical insight by examining institutional ownership, which are reported in public companies’ most recent 13F filings. Intercept Pharmaceuticals, Inc. (ICPT) has 0 billion shares outstanding currently, 73.77% of which belong to institutional investors. Those institutional holdings amount to $1.08 billion.
Additionally, according to the most recent 13F filing from Intercept Pharmaceuticals, Inc. (ICPT), there were 33 new positions totaling 1,460,799 shares of the company’s stock. There were 41 sold out positions, on the other hand, totaling 2,558,957 shares.Short, Medium and Long Term Indicators
A stock’s average trade volume, as recorder over the short, medium and long terms, is helpful to analyze in order to gain a better understanding of trading activity and investor sentiment. Intercept Pharmaceuticals, Inc. (ICPT) has had a 20-day average volume of 676,650 shares, with an average of 100% of short term indicators pointed at Sell.
The stock’s 50-day average volume has been 785,662 shares, with an average of 100% of medium term indicators pointing toward Sell. Finally, its 100-day average volume is 1,255,893 shares with 100% of long-term indicators pointing to Sell.